An outbreak of multiresistant tuberculosis from Eastern Europe in the Netherlands;Een uitbraak van multiresistente tuberculose uit Oost-Europa in Nederland

Nederlands Tijdschrift voor Geneeskunde

Volumn 149, Issue 35, 2005, Pages 1921-1924

  De Vries, G ^a,b,c   Van Altena, R ^a,d   Van Soolingen, D ^a,e   Broekmans, J F ^a,d   Van Hest, N A H ^a,b,c  

^a Public Health Service of the Rotterdam Region   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c Afdeling Tuberculose   (Netherlands)

^d KNCV TUBERCULOSIS FOUNDATION   (Netherlands)

^e NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; DNA FINGERPRINTING; EASTERN EUROPE; FEMALE; HUMAN; IMMIGRANT; INCIDENCE; LUNG TUBERCULOSIS; MORTALITY; NETHERLANDS; PROPHYLAXIS; THORAX RADIOGRAPHY; TUBERCULOSIS CONTROL;

ADULT; CONTACT TRACING; DISEASE OUTBREAKS; DNA FINGERPRINTING; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EUROPE, EASTERN; FEMALE; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; NETHERLANDS; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 24044517847     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. World Health Organization (WHO). Anti-tuberculosis drug resistance in the world: third global report (WHO/CDS.TB/2004.XXX). Genève: WHO; 2004.
2. Espinal MA, Laszlo A, Simonsen L, Boulahbal F, Kim SJ, Reniero A, et al. Global trends in resistance to antituberculosis drugs. N Engl J Med 2001;344:1294-303.
3. Frieden TF, Sterling TR, Munsiff SS, Watt CJ, Dye C. Tuberculosis. Lancet 2003;362:887-99.
4. Lambregts-van Weezenbeek CSB, Klingeren B van, Veen J. Resistentie bij Mycobacterium tuberculosis in Nederland. Ned Tijdschr Geneeskd 1996;140:2187-91.
5. Frieden TF, Fujiwara PI, Washko IM, Hamburg MA. Tuberculosis in New York City: turning the tide. N Engl J Med 1995;333:229-33.
6. Hannan MM, Peres H, Maltez F, Hayward AC, Machado J, Morgado A, et al. Investigation and control of a large outbreak of multi-drug resistant tuberculosis at a central Lisbon hospital. J Hosp Infect 2001; 47:91-7.
7. Breathnach AS, Ruiter A de, Holdsworth GM, Bateman NT, O'Sullivan DG, Rees PJ, et al. An outbreak of multi-drug-resistant tuberculosis in a London teaching hospital. J Hosp Infect 1998;39:111-7.
8. Soolingen D van, Lambregts-van Weezenbeek CSB, Haas P de, Veen J, Embden JDA van. Transmissie van gevoelige en resistente Mycobacterium tuberculosis-stammen in Nederland, 1993-1995, onderzocht met DNA-'fingerprinting'. Ned Tijdschr Geneeskd 1996;140:2286-9.
9. Lambregts-van Weezenbeek CSB, Keizer ST, Sebek MMGG, Schepp-Beelen JCHM, Loo CJ van der. Transmissie van multiresistente tuberculose in een Nederlands ziekenhuis. Ned Tijdschr Geneeskd 1996; 140:2293-5.
10. Bastian I, Colebunders R. Treatment and prevention of multidrug-resistant tuberculosis. Drugs 1999;58:633-61.
11. Geerligs WA, Altena Rvan, Lange WCM de, Soolingen D van, Werf TS van der. Multidrug-resistant tuberculosis: long-term treatment outcome in the Netherlands. Int J Tuberc Lung Dis 2000;4:758-64.
12. Gleissberg V. The threat of multidrug resistance: is tuberculosis ever unbeatable or uncontrollable? Lancet 1999;353:998-9.
13. Mukherjee JS, Rich ML, Socol AR, Joseph JK, Viru FA, Shin SS, et al. Programmes and principles in treatment of multidrug-resistant tuberculosis. Lancet 2004;363:474-81.
14. Goble M, Iseman MD, Madsen LA, Waite D, Ackerson L, Horsburgh jr CR. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med 1993;328:527-32.
15. Joint Tuberculosis Committee of the British Thoracic Society. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Thorax 1998;53:536-48.
16. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000;161 (4 Pt 2):S221-47.
17. Kuyvenhoven JV, Broekmans JF. Honderd jaar Koninklijke Nederlandse Centrale Vereniging tot bestrijding der Tuberculose (KNCV). Ned Tijdschr Geneeskd 2003;147:1869-74.
18. Versterken Infectieziektebestrijding. Brief Minister Hoogervorst aan de Tweede Kamer. 13 Oktober 2004 [PG/ZP 2.507.890].